Skip to content

Clinical trials

Phase 3 Hyperlipidemias trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Phase: Phase 3 Country / region: South Korea Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20071
20111
20122
20138
20143
20151
20161
20174
20211
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Unknown status3
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Amgen4
Hanmi Pharmaceutical Company Limited4
Yuhan Corporation3
Daewoong Pharmaceutical Co. LTD.2
Novartis Pharmaceuticals2
Chong Kun Dang Pharmaceutical1
HK inno.N Corporation1
HanAll BioPharma Co., Ltd.1
IlDong Pharmaceutical Co Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias26
Hypertension11
Hypercholesterolemia4
Cardiovascular Diseases2
Myocardial Infarction2
Stroke2
Acute Coronary Syndrome1
Atherosclerosis1
Diabetes Mellitus1
Dyslipidemias1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.